Alleima AB (publ) (STO:ALLEI)
68.50
-0.85 (-1.23%)
Aug 1, 2025, 5:29 PM CET
CTI BioPharma Revenue
Alleima AB had revenue of 4.77B SEK in the quarter ending June 30, 2025, a decrease of -11.08%. This brings the company's revenue in the last twelve months to 19.51B, down -1.26% year-over-year. In the year 2024, Alleima AB had annual revenue of 19.69B, down -4.73%.
Revenue (ttm)
19.51B
Revenue Growth
-1.26%
P/S Ratio
0.88
Revenue / Employee
3.04M
Employees
6,309
Market Cap
17.14B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 19.69B | -978.00M | -4.73% |
Dec 31, 2023 | 20.67B | 2.26B | 12.30% |
Dec 31, 2022 | 18.41B | 4.56B | 32.92% |
Dec 31, 2021 | 13.85B | -78.00M | -0.56% |
Dec 31, 2020 | 13.93B | -1.73B | -11.05% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Boliden AB | 91.38B |
Svenska Cellulosa Aktiebolaget SCA | 22.91B |
Holmen AB | 23.96B |
SSAB AB | 99.14B |
HEXPOL AB | 20.05B |
Billerud AB | 43.73B |
Gränges AB | 26.14B |
Nordic Paper Holding AB | 4.67B |
Alleima AB News
- 6 months ago - Alleima AB (STU:M46) Q4 2024 Earnings Call Highlights: Strong Revenue Growth Amid Economic ... - GuruFocus
- 6 months ago - Q4 2024 Alleima AB Earnings Call Transcript - GuruFocus